Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment.
Not yet recruiting · NCT06374901 · Registry updated 2024-04-19Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tislelizumab Combined With Neoadjuvant Chemotherapy Used in the Perioperative Treatment. | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, neoplasm, stomach disorder | Not yet recruiting | Phase 2 | 2024-04-19 | NCT06374901 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital) | Hangzhou | China | 1 |